The figure illustrates the inhibitory effect of NM23-H1 on Smad3 nuclear translocation in the TGF-β signaling pathway. Panels A and B show NM23-H1's impact on the association of activated TGF-β receptor with Smad7 and STRAP, respectively. Panels C and D demonstrate NM23-H1's modulation of Smad3 localization in Hep3B cells. Panel E extends this analysis with NM23-H1(C145S). Quantitative analysis, using densitometry, shows the relative Smad3 expression levels compared to controls. These experiments collectively highlight NM23-H1's role in regulating Smad3 and its association with TGF-β signaling components. The data are representative of multiple independent experiments.
Serine-threonine kinase receptor-associated protein is an protein that in humans is encoded by the STRAPgene.
STRAP is a WD40-repeat protein that binds both the type I and type II TGF-β receptors. Its primary function is to recruit and stabilize the inhibitory Smad, SMAD7, at the activated TGF-β receptor complex.
By stabilizing this STRAP/SMAD7/TGF-β receptor complex, STRAP sterically blocks SMAD2 and SMAD3 from binding to the activated type I TGF-β receptor, preventing its phosphorylation and thus blunting TGF-β mediated up-regulation of gene expression.
Apoptosis
STRAP binds directly to ASK1 through ASK1's C-terminal domain and the fourth and sixth WD40 repeats of STRAP. This binding allows STRAP to be phosphorylated by ASK1, and the resulting complex reduces ASK1's downstream signaling to the JNK and p38stress-response pathways. It does so by helping to stabilize ASK1's association with its own inhibitory proteins, thioredoxin and 14-3-3. It also reduces ASK1's ability to form a complex with its downstream target MKK3. Through this mechanism, STRAP protects cells from H2O2-induced, ASK1-driven apoptosis, favoring cell survival. STRAP has also been described as a positive regulator of PDK1 signaling.
STRAP also inhibits TGF-β receptor signaling by stabilizing the inhibitory protein SMAD7, which in turn limits activation of SMAD2 and SMAD3. This pathway is frequently dysregulated in cancer and elevated STRAP expression has been reported in several tumor types, including colorectal and lung carcinoma, where it promotes proliferation and reduces apoptosis.
↑Halder SK, Anumanthan G, Maddula R, Mann J, Chytil A, Gonzalez AL, etal. (June 2006). "Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis". Cancer Research. 66 (12): 6156–6166. doi:10.1158/0008-5472.CAN-05-3261. PMID16778189.
Matsuda S, Katsumata R, Okuda T, Yamamoto T, Miyazaki K, Senga T, etal. (January 2000). "Molecular cloning and characterization of human MAWD, a novel protein containing WD-40 repeats frequently overexpressed in breast cancer". Cancer Research. 60 (1): 13–17. PMID10646843.
Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL (March 2005). "Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity". Science. 307 (5715). New York, N.Y.: 1603–1609. Bibcode:2005Sci...307.1603O. doi:10.1126/science.1105718. PMID15761148. S2CID41013935.
Guo D, Han J, Adam BL, Colburn NH, Wang MH, Dong Z, etal. (December 2005). "Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress". Biochemical and Biophysical Research Communications. 337 (4): 1308–1318. Bibcode:2005BBRC..337.1308G. doi:10.1016/j.bbrc.2005.09.191. PMID16236267.